Ahlke Heydemann

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Venues

Biomedicines

Nutrients

Archivum immunologiae et therapiae experimentalis

Journal of diabetes research

University of Illinois at Chicago

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois at Chicago

United States

Assistant Professor :: Physiology and Biophysics

Publications

Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, Paulina Langa, Sonia Brodowska, Krzysztof Siemionow, Ahlke Heydemann
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model. Biomedicines 12 (3) (2024)
Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, Paulina Langa, Sonia Brodowska, Krzysztof Siemionow, Ahlke Heydemann
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model. Biomedicines 12 (3) (2024)
Ahlke Heydemann, Maria Siemionow
A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies. Biomedicines 11 (3) (2023)
Ahlke Heydemann, Maria Siemionow
A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies. Biomedicines 11 (3) (2023)
Maria Siemionow, Sonia Brodowska, Paulina Langa, Kristina Zalants, Katarzyna Kozlowska, Wictoria Grau-Kazmierczak, Ahlke Heydemann
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model. Archivum immunologiae et therapiae experimentalis 70 (1) (2022)
Aqsa Iqbal, Ulrike May, Stuart N Prince, Tero A H Järvinen, Ahlke Heydemann
Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology. Pharmaceutics 13 (9) (2021)
Ahlke Heydemann
Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies. Nutrients 10 (6) (2018)
Ahlke Heydemann
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus. Journal of diabetes research 2016 (2016)

Ahlke Heydemann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ahlke Heydemann